Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 82,832 shares at $20.22 ($1.6M) on 2019-03-01, disclosed to the SEC on 2019-03-04.
Open-market sale of $1.6M VNDA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.22 | 6,500 | $131K | 8.1% |
| 2 | $19.41 | 38,166 | $741K | 45.9% |
| 3 | $19.41 | 38,166 | $741K | 45.9% |
| Total | $19.47 avg | 82,832 | $1.6M | 100% |
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |